Search research articles
Contact Us
Filters
Showing results (81-90 of 336) with videos related to
Page
of 34
Sort By:
Deutsches Arzteblatt International
|
July 13, 2018
The Diagnosis and Treatment of Primary CNS Lymphoma
Louisa von Baumgarten, Gerald Illerhaus, Agnieszka Korfel, et al.
Clinical Lymphoma & Myeloma
|
May 2, 2009
Biomarkers and prognosis in malignant lymphomas
Anton Hagenbeek, Randy D Gascoyne, Martin Dreyling, et al.
Haematologica
|
June 1, 2005
Microsatellite instability and p53 mutations are characteristic of subgroups of acute myeloid leukemia but independent events
Gerhard Herzog, Juxian Lu-Hesselmann, Yvonne Zimmermann, et al.
The Cochrane Database of Systematic Reviews
|
September 14, 2012
Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia
Liat Vidal, Anat Gafter-Gvili, Ronit Gurion, et al.
Histopathology
|
March 16, 2011
Follicular dendritic cells in follicular lymphoma and types of non-Hodgkin lymphoma show reduced expression of CD23, CD35 and CD54 but no association with clinical outcome
Mi Kyung Jin, Eva Hoster, Martin Dreyling, et al.
Leukemia & Lymphoma
|
August 4, 2015
Temsirolimus inhibits cell growth in combination with inhibitors of the B-cell receptor pathway
Anna-Katharina Zoellner, Stephan Bayerl, Grit Hutter, et al.
European Journal of Haematology
|
April 5, 2018
Transient antagonism of anti-CD20 monoclonal antibodies and PI3K inhibitor idelalisib in DLBCL cell lines
Anna-Katharina Zoellner, Nico Peter, Yvonne Zimmermann, et al.
Leukemia & Lymphoma
|
February 1, 2017
Recent advances and future directions in mantle cell lymphoma research: report of the 2016 mantle cell lymphoma consortium workshop
Brad S Kahl, Martin Dreyling, Leo I Gordon, et al.
Leukemia & Lymphoma
|
March 11, 2015
Everolimus maintenance in patients with mantle cell lymphoma not eligible for intensive therapy: results of a prematurely closed phase 2 study
Susanne Schreiber, Alexander Hoellein, Thomas Decker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 22, 2004
Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group
Georg Lenz, Martin Dreyling, Eva Schiegnitz, et al.
Page
of 34
Search research articles
Search
Showing results (81-90 of 336) with videos related to
Sort By:
Page
of 34
Deutsches Arzteblatt International
|
July 13, 2018
The Diagnosis and Treatment of Primary CNS Lymphoma
Louisa von Baumgarten, Gerald Illerhaus, Agnieszka Korfel, et al.
Clinical Lymphoma & Myeloma
|
May 2, 2009
Biomarkers and prognosis in malignant lymphomas
Anton Hagenbeek, Randy D Gascoyne, Martin Dreyling, et al.
Haematologica
|
June 1, 2005
Microsatellite instability and p53 mutations are characteristic of subgroups of acute myeloid leukemia but independent events
Gerhard Herzog, Juxian Lu-Hesselmann, Yvonne Zimmermann, et al.
The Cochrane Database of Systematic Reviews
|
September 14, 2012
Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia
Liat Vidal, Anat Gafter-Gvili, Ronit Gurion, et al.
Histopathology
|
March 16, 2011
Follicular dendritic cells in follicular lymphoma and types of non-Hodgkin lymphoma show reduced expression of CD23, CD35 and CD54 but no association with clinical outcome
Mi Kyung Jin, Eva Hoster, Martin Dreyling, et al.
Leukemia & Lymphoma
|
August 4, 2015
Temsirolimus inhibits cell growth in combination with inhibitors of the B-cell receptor pathway
Anna-Katharina Zoellner, Stephan Bayerl, Grit Hutter, et al.
European Journal of Haematology
|
April 5, 2018
Transient antagonism of anti-CD20 monoclonal antibodies and PI3K inhibitor idelalisib in DLBCL cell lines
Anna-Katharina Zoellner, Nico Peter, Yvonne Zimmermann, et al.
Leukemia & Lymphoma
|
February 1, 2017
Recent advances and future directions in mantle cell lymphoma research: report of the 2016 mantle cell lymphoma consortium workshop
Brad S Kahl, Martin Dreyling, Leo I Gordon, et al.
Leukemia & Lymphoma
|
March 11, 2015
Everolimus maintenance in patients with mantle cell lymphoma not eligible for intensive therapy: results of a prematurely closed phase 2 study
Susanne Schreiber, Alexander Hoellein, Thomas Decker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 22, 2004
Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group
Georg Lenz, Martin Dreyling, Eva Schiegnitz, et al.
Page
of 34